(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PULSE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PULSE

ST13

US500000098298153

Class

40, 42

Filing

98298153

Registration

8091061

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

04/03/2026

Trademark type

Word

Nice classes

40, 42

Filing date

12/04/2023

Registration date

01/06/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/06/2026

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

33

Owner location

MONT-SAINT-GUIBERT, BE

Examiner

GIBBONS, BRIAN R

Law office

L60

Current location

INTENT TO USE SECTION

Holders and representatives

Holders

CELYNTRA THERAPEUTICS SA
Ncardia B.V.

Representatives

Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.

Technical classification

Nice Classes

Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 40

Custom manufacturing of cell culture and cell therapy apparatus and equipment for others; custom manufacture of therapeutic cellsmedicinescell therapies and gene edited cell therapies for others; custom manufacture of cellular therapies; informationadvice and consultancy in relation to all the aforesaid

Class 42

Platform as a service (PaaS) featuring computer software platforms for developing cell therapies; providing temporary use of web-based software platforms for developing and characterizing cell lines; providing temporary use of non-downloadable computer software platforms for manufacturing cell-based therapies and analyzing data for purposes of process optimization and quality control; laboratory research in the field of biotechnology; scientific researchdesign and technological development services in the field of biotechnologyfor the pharmaceutical and medical industry; scientific researchdesign and technological development services in the fields of scientific cell culturescell therapiesgene-edited cell therapy equipment and apparatus; scientific researchdesign and development of manufacturing equipmentmanufacturing systems and manufacturing processes in the fields of cell culturecell therapygene edited cell therapyfor others; scientific consultation services in the field of biotechnologyspecifically in relation to cell culturecell therapygene edited cell therapy manufacturing; providing information with respect to scientific research in the field of stem cellscell therapy and edited cell gene therapy; calibration of scientific apparatusmachines and equipment used for cell culturecell therapy and edited cell gene therapy; industrial biotechnology statistical analysis to extract insights from cell line development experiments and data

Publications

History of USPTO decisions and trademark events.

42 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/06/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

01/06/2026

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

12/12/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/01/2025

IUCN

NOTICE OF ALLOWANCE CANCELLED

06/30/2025

EX1G

SOU EXTENSION 1 GRANTED

06/30/2025

EXT1

SOU EXTENSION 1 FILED

06/30/2025

EEXT

SOU TEAS EXTENSION RECEIVED

06/30/2025

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

06/30/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

01/14/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/03/2024

PUBO

PUBLISHED FOR OPPOSITION

12/03/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/27/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/06/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/25/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/25/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

10/25/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/16/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/07/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

08/07/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/07/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/07/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/07/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

08/07/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

08/04/2024

GNFR

FINAL REFUSAL E-MAILED

08/04/2024

CNFR

FINAL REFUSAL WRITTEN

08/04/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/10/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/10/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/10/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/10/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/10/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/10/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/21/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/21/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/21/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/23/2024

GNRT

NON-FINAL ACTION E-MAILED

03/23/2024

CNRT

NON-FINAL ACTION WRITTEN

03/23/2024

DOCK

ASSIGNED TO EXAMINER

03/19/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/28/2024

NWAP

NEW APPLICATION ENTERED

12/04/2023

Continuous trademark protection

Get notified about every new filing that threatens PULSE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.